An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine

被引:26
作者
Marez, D
Legrand, M
Sabbagh, N
LoGuidice, JM
Boone, P
Broly, F
机构
关键词
D O I
10.1007/s004390050113
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The identification of a novel CYP2D6 allele from a healthy Caucasian poor metabolizer was achieved by using a previously described polymerase chain reaction/single-strand conformation polymorphism strategy. Among the four point mutations that this allele carries, a missense mutation in exon 1 (212 G --> A or D6-H) seems to be responsible for the loss of CYP2D6 function. Although the mutation D6-H has a low prevalence in a randomly selected population of healthy Caucasians, its identification should further increase the phenotype prediction rate by genotyping.
引用
收藏
页码:668 / 670
页数:3
相关论文
共 19 条
[1]   An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis [J].
Broly, F ;
Marez, D ;
Sabbagh, N ;
Legrand, M ;
Millecamps, S ;
LoGuidice, JM ;
Boone, P ;
Meyer, UA .
PHARMACOGENETICS, 1995, 5 (06) :373-384
[2]   DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].
BROLY, F ;
GAEDIGK, A ;
HEIM, M ;
EICHELBAUM, M ;
MORIKE, K ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558
[3]  
BROLY F, 1996, HUM GENET, V96, P601
[4]   CYP2D6 GENOTYPE DETERMINATION IN THE DANISH POPULATION [J].
BROSEN, K ;
NIELSEN, PN ;
BRUSGAARD, K ;
GRAM, LF ;
SKJODT, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (03) :221-225
[5]   ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION [J].
DAHL, ML ;
JOHANSSON, I ;
PALMERTZ, MP ;
INGELMANSUNDBERG, M ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :12-17
[6]  
DALY AK, 1995, HUM GENET, V95, P337
[7]   GENOTYPING FOR POLYMORPHISMS IN XENOBIOTIC METABOLISM AS A PREDICTOR OF DISEASE SUSCEPTIBILITY [J].
DALY, AK ;
CHOLERTON, S ;
ARMSTRONG, M ;
IDLE, JR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 :55-61
[8]  
EVERT B, 1994, N-S ARCH PHARMACOL, V350, P434
[9]   CLONING AND SEQUENCING OF A NEW NONFUNCTIONAL CYP2D6 ALLELE - DELETION OF T-1795 IN EXON-3 GENERATES A PREMATURE STOP CODON [J].
EVERT, B ;
GRIESE, EU ;
EICHELBAUM, M .
PHARMACOGENETICS, 1994, 4 (05) :271-274
[10]   PHARMACOGENETIC PHENOTYPING AND GENOTYPING - PRESENT STATUS AND FUTURE POTENTIAL [J].
GONZALEZ, FJ ;
IDLE, JR .
CLINICAL PHARMACOKINETICS, 1994, 26 (01) :59-70